Drug General Information (ID: DDIFEHPKQ6)
  Drug Name Glimepiride Drug Info Amitriptyline Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antidiabetic Agents Analgesics
  Structure

 Mechanism of Glimepiride-Amitriptyline Interaction (Severity Level: Moderate)
     Increased risk of hypoglycemia Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Glimepiride Amitriptyline
      Mechanism Antidiabetic agent
Sulfonylureas 
Increase the hypoglycemic effects of sulfonylureas
      Key Mechanism Factor 1
Factor Name Hypoglycemia
Factor Description Hypoglycemia is a condition in which your blood sugar (glucose) level is below the standard range. It causes irregular or rapid heartbeat, pale skin, numbness of the lips, tongue or cheeks, and sweating.
      Mechanism Description
  • Increased risk of hypoglycemia by the combination of Glimepiride and Amitriptyline 

Recommended Action
      Management Patients receiving this combination should be advised to regularly monitor their blood sugar, counseled on how to recognize and treat hypoglycemia (e.g., headache, dizziness, drowsiness, nausea, tremor, hunger, weakness, or palpitations) and to notify their physician if it occurs. The sulfonylurea dosage may require reduction in affected patients.

References
1 Pond SM, Graham GG, Birkett DJ, Wade DN "Effects of tricyclic antidepressants on drug metabolism." Clin Pharmacol Ther 18 (1975): 191-9
2 True BL, Perry PJ, Burns EA "Profound hypoglycemia with the addition of a tricyclic antidepressant to maintenance sulfonylurea therapy." Am J Psychiatry 144 (1987): 1220-1
3 Zogno MG, Tolfo L, Draghi E "Hypoglycemia caused by maprotiline in a patient taking oral antidiabetics." Ann Pharmacother 28 (1994): 406